Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atherolive in Hypertension
NCT05636826Phase 3Completed
- Sponsor
- Université de Monastir
- Start
- Dec 2023
- Primary completion
- Nov 2024
- Countries
- 1
01
Overview
A Phase 3 trial of atherolive in hypertension (HTN), sponsored by Université de Monastir. Started Dec 2023; status: completed.
02
Drugs
atherolive
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT05636826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05636826.